Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(20%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
1
20%
Ph not_applicable
2
40%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(3)
Other(1)

Detailed Status

Completed3
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (33.3%)
N/A2 (66.7%)

Trials by Status

recruiting120%
unknown120%
completed360%

Recent Activity

1 active trials
Showing 5 of 5
completednot_applicable

DECT for Differentiating Intracerebral Hemorrhage From Contrast Extravasation

NCT05675774
completed

LUng voluMe reductIoN by DuAl ENergy CT Evaluation (LUMINANCE) Study

NCT05816239
recruitingphase_4

CT TAVR Abdomen Study

NCT05758701
completed

Unifying Advanced Treatment With Advanced Imaging

NCT03404076
unknownnot_applicable

Diagnostic Value of DECT Scan Compared to Diagnostic Needle Aspiration

NCT03038386

Clinical Trials (5)

Showing 5 of 5 trials
NCT05675774Not Applicable

DECT for Differentiating Intracerebral Hemorrhage From Contrast Extravasation

Completed
NCT05816239

LUng voluMe reductIoN by DuAl ENergy CT Evaluation (LUMINANCE) Study

Completed
NCT05758701Phase 4

CT TAVR Abdomen Study

Recruiting
NCT03404076

Unifying Advanced Treatment With Advanced Imaging

Completed
NCT03038386Not Applicable

Diagnostic Value of DECT Scan Compared to Diagnostic Needle Aspiration

Unknown

All 5 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
5